<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
  <title>CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review - VetSRev</title>
  <link rel="stylesheet" href="/vendor/bootstrap-4.3.1.min.css">
  <link rel="stylesheet" href="/vendor/fontawesome-5.8.1.min.css">

  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,700;1,400&display=swap" rel="stylesheet">

  <link rel="stylesheet" href="/assets/style.css" media="screen" type="text/css">

  <link rel="apple-touch-icon" sizes="180x180" href="/apple-touch-icon.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/favicon-16x16.png">
  <link rel="manifest" href="/site.webmanifest">
</head>

<body>
  <!-- HEADER -->
  <div class="header">
    <div class="container">
      <img src="/assets/CEVMLogo.png" alt="logo"/>
      <div class="title">
        <h1>VetSRev</h1>
        <p class="hidden-xs">Database of veterinary systematic reviews</p>
      </div>
    </div>
  </div>

  <!-- Navigation -->
  <div class="container">
    <nav class="navbar navbar-expand navbar-light bg-light">
      <button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarSupportedContent" aria-controls="navbarSupportedContent" aria-expanded="false" aria-label="Toggle navigation">
        <span class="navbar-toggler-icon"></span>
      </button>

      <div class="collapse navbar-collapse" id="navbarSupportedContent">
        <ul class="navbar-nav mr-auto">
          <li class="nav-item"><a class="nav-link" href="/">Home</a></li>
          <li class="nav-item"><a class="nav-link" href="/about.html">About VetSRev</a></li>
        </ul>
      </div>
    </nav>
  </div>

  <!-- CONTENT -->
  <div class="container">
  <div class="publication">
  <h1>CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review</h1>
  <h2>Babačić, H. and Mehta, A. and Merkel, O. and Schoser, B.</h2>

  
  <p>PLoS One (2019) 14: e0212198</p>
  

  
  <p>DOI: <a href="https://doi.org/10.1371/journal.pone.0212198">10.1371/journal.pone.0212198</a></p>
  

  
  <h2>Abstract</h2>
  <p>INTRODUCTION: The system of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated proteins (cas) is a new technology that allows easier manipulation of the genome. Its potential to edit genes opened a new door in treatment development for incurable neurological monogenic diseases (NMGDs). The aim of this systematic review was to summarise the findings on the current development of CRISPR-cas for therapeutic purposes in the most frequent NMGDs and provide critical assessment. METHODS AND DATA ACQUISITION: We searched the MEDLINE and EMBASE databases, looking for original studies on the use of CRISPR-cas to edit pathogenic variants in models of the most frequent NMGDs, until end of 2017. We included all the studies that met the following criteria: 1. Peer-reviewed study report with explicitly described experimental designs; 2. In vitro, ex vivo, or in vivo study using human or other animal biological systems (including cells, tissues, organs, organisms); 3. focusing on CRISPR as the gene-editing method of choice; and 5. featured at least one NMGD. RESULTS: We obtained 404 papers from MEDLINE and 513 from EMBASE. After removing the duplicates, we screened 490 papers by title and abstract and assessed them for eligibility. After reading 50 full-text papers, we finally selected 42 for the review. DISCUSSION: Here we give a systematic summary on the preclinical development of CRISPR-cas for therapeutic purposes in NMGDs. Furthermore, we address the clinical interpretability of the findings, giving a comprehensive overview of the current state of the art. Duchenne’s muscular dystrophy (DMD) paves the way forward, with 26 out of 42 studies reporting different strategies on DMD gene editing in different models of the disease. Most of the strategies aimed for permanent exon skipping by deletion with CRISPR-cas. Successful silencing of the mHTT gene with CRISPR-cas led to successful reversal of the neurotoxic effects in the striatum of mouse models of Huntington’s disease. Many other strategies have been explored, including epigenetic regulation of gene expression, in cellular and animal models of: myotonic dystrophy, Fraxile X syndrome, ataxias, and other less frequent dystrophies. Still, before even considering the clinical application of CRISPR-cas, three major bottlenecks need to be addressed: efficacy, safety, and delivery of the systems. This requires a collaborative approach in the research community, while having ethical considerations in mind.</p>
  

  <h2>Citation</h2>
  <p class="citation"><span id="babacic_crispr-cas_2019">Babačić, H., Mehta, A., Merkel, O., &amp; Schoser, B. (2019). CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review. <i>PLoS One</i>, <i>14</i>(2), e0212198. https://doi.org/10.1371/journal.pone.0212198 <b>Animals, Humans, Mice, Disease Models, Animal, Medline, *Gene Transfer Techniques, Gene Silencing, *CRISPR-Cas Systems, *DNA Repeat Expansion, *Genetic Diseases, Inborn/genetics/pathology/therapy, *Neuromuscular Diseases/genetics/pathology/therapy, Gene Editing/*methods/trends</b></span> </p>


  <h2>Keywords</h2>
  <ul>
    
    
      <li>Animals</li>
    
      <li>Humans</li>
    
      <li>Mice</li>
    
      <li>Disease Models</li>
    
      <li>Animal</li>
    
      <li>Medline</li>
    
      <li>*Gene Transfer Techniques</li>
    
      <li>Gene Silencing</li>
    
      <li>*CRISPR-Cas Systems</li>
    
      <li>*DNA Repeat Expansion</li>
    
      <li>*Genetic Diseases</li>
    
      <li>Inborn/genetics/pathology/therapy</li>
    
      <li>*Neuromuscular Diseases/genetics/pathology/therapy</li>
    
      <li>Gene Editing/*methods/trends</li>
    
  </ul>

</div>

  </div>

  <!-- FOOTER -->
  <div class="container">
    <div class="footer">


      <h3>VetSRev</h3>
      <p class="strap">Database of veterinary systematic reviews</p>

      <p>To cite this resource please use the following:</br>
      Veterinary Systematic Review database (2021) VetSRev database (Version 2.0). Available at: https://vetsrev.nottingham.ac.uk.</p>


      <p class="smallprint"><a href="/cookies.html">Cookies policy</a></p>

    </div>
  </div>

  <!-- Cookie-Alert -->
  <div class="alert alert-dark alert-dismissible cookiealert" role="alert">

    We'd like to set some analytics cookies to help us improve our website.

    <a href="/cookies/">Learn more.</a>
    <button type="button" class="btn btn-outline-secondary btn-sm declinecookies" data-dismiss="alert">Decline</button>
    <button type="button" class="btn btn-primary btn-sm acceptcookies">Accept</button>

    <button type="button" class="close" data-dismiss="alert" aria-label="Close">
      <span aria-hidden="true">&times;</span>
    </button>
  </div>


  <!-- jQuery first, then Popper.js, then Bootstrap JS -->
  <script src="/vendor/jquery-3.5.1.min.js"></script>
  <script src="/vendor/popper.min.js "></script>
  <script src="/vendor/bootstrap-4.3.1.min.js "></script>

  


  


  <!-- cookies and Google Analytics-->
  <script src="/assets/cookies.js "></script>

</body>
</html>
